CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 enrolled
Drug / intervention
Vitamin D +1 moredrug
Likely dose
Vitamin D 50,000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00948298
NCT00948298N/ACompleted

The Effect of Cholecalciferol (Vitamin D3) on Vascular Function and Cardiovascular Risk Factors

Charles Drew University of Medicine and Science·interventional·Posted Jul 29, 2009·Updated Jul 17, 2018

In Brief

A clinical study evaluating Vitamin D and Placebo for Vitamin D Deficiency. Completed, enrolled 130 participants.

Detailed Summary

Vitamin D is a natural nutrient. A little comes from our normal daily diet. Most of it comes from our skin after we have been in sunlight. If we have darker skin, we make less vitamin D. Vitamin D balances the calcium in our body. If our vitamin D levels get too low, it can cause health problems. It may increase our chance of getting high blood pressure or diabetes. Another problem we may have if our vitamin D levels are low is that our blood vessels may not work normally. These are important health problems for anyone. Because African Americans have darker skin, they are more likely than most other racial/ethnic groups to have low vitamin D levels. This study will look at treating African Americans with low vitamin D levels. The goal of this study is to see how vitamin D helps blood vessels work. The investigators will do this study in African Americans who are overweight, have high blood pressure and have low vitamin D levels. The investigators will see if getting the vitamin D level to a normal value will improve how blood vessels work. The dose of vitamin D that will be given in this study is a high dose that is given to people with low vitamin D levels.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 29, 2009
Enrollment StartJul 1, 2009
Primary CompletionJul 1, 2011
Study CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 16.9 years ago

Interventions

Vitamin Ddrug

Two 50,000 IU tablets of oral Vitamin D3 will be given every 4 weeks.

Placebodrug

Two tablets of oral placebo (microcrystalline cellulose),matching in appearance to the Vitamin D3, will be given every 4 weeks.